SCHEMBL6567996

SCHEMBL6567996

COC(=O)c1cc(NC(=O)NCc2ccc(O)c(OC)c2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.53
LMNA P02545 2/20 0.46
CASR P41180 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
GABRP O00591 1/20 0.45
GABRD O14764 1/20 0.45
GABRA1 P14867 1/20 0.45
GABRB1 P18505 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA5 P31644 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
GABRA4 P48169 1/20 0.45
GABRE P78334 1/20 0.45
GABRA6 Q16445 1/20 0.45
GABRG1 Q8N1C3 1/20 0.45
GABRG3 Q99928 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566826 0.88 GAA (0.54) GAALMNACASRSMN1; SMN2MEN1
SCHEMBL6566681 0.84 GAA (0.54) GAALMNASMN1; SMN2QPCTMEN1
SCHEMBL6564606 0.84 CNR1 (0.58) GAACASRSMN1; SMN2MEN1KMT2A
SCHEMBL6566529 0.84 ALDH1A1 (0.56) CASRALDH1A1L3MBTL1ROCK2
SCHEMBL6566505 0.83 LMNA (0.51) GAALMNACASRSMN1; SMN2ALDH1A1
SCHEMBL6565062 0.83 KMT2A (0.62) HPGDMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL6565755 0.81 L3MBTL1 (0.63) SMN1; SMN2HPGDKMT2AALDH1A1L3MBTL1
SCHEMBL6565846 0.81 MEN1 (0.52) GAALMNACASRSMN1; SMN2MEN1
SCHEMBL6566741 0.81 MEN1 (0.52) GAALMNACASRSMN1; SMN2MEN1
SCHEMBL6564452 0.81 KMT2A (0.56) GAALMNACASRSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 GAA 3305/4885LMNA 4043/4885CASR 1621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.